Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Resources

PER Pulse™ Recaps for Cancer Summaries and Commentaries™: Update From San Diego - Advances in the Treatment of Multiple Myeloma

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

Cancer Summaries and Commentaries™: Update from San Diego - Advances in the Treatment of Multiple Myeloma

Activity Overview

This online activity is designed to update physicians on data that were recently presented in San Diego so they can assess and apply the findings to their clinical practices in managing patients with multiple myeloma. Coverage includes phase III trial data on the treatment of multiple myeloma and promising results from phase I and II studies of emerging management strategies for patients with relapsed/refractory disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Merck Sharp & Dohme Corp.

CME Activity Table of Contents

Primary Results From the Randomized Phase III StaMINA Trial

Efficacy and Safety Data From the Phase II Study of Pembrolizumab, Pomalidomide, and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Final Results from the Phase I Trial of Selinexor, Carfilzomib, and Dexamethasone for Relapsed/Refractory Multiple Myeloma

Instructions For This Activity & Receiving Credit

You will need to login to participate in the activity.

Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.

At the end of the activity, "educational content/audio files" will be available for your reference.

In order to receive a CME certificate, participants must complete the activity.

Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational activity is directed toward medical and surgical oncologists who treat patients with multiple myeloma. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of patients with multiple myeloma may also participate.

Learning Objectives

At the conclusion of this activity, participants should be better prepared to:

Describe the clinical study design and efficacy/safety endpoints from recent/ongoing trials in patients with multiple myeloma

Explain key efficacy and safety results concerning the use of novel strategies that have been evaluated in patients with multiple myeloma

Discuss recent clinical trial evidence in the context of evolving treatment paradigms in the management of patients with multiple myeloma

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

The staff of Physicians' Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®, or any of the companies that provided commercial support for this activity.